Amanote Research
Register
Sign In
Genomic Analysis Reveals RhoC as a Potential Marker in Hepatocellular Carcinoma With Poor Prognosis
British Journal of Cancer
- United Kingdom
doi 10.1038/sj.bjc.6601749
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
May 11, 2004
Authors
W Wang
L-Y Yang
G-W Huang
W-Q Lu
Z-L Yang
J-Q Yang
H-L Liu
Publisher
Springer Nature
Related search
Expression of P-Glycoprotein in Hepatocellular Carcinoma: A Potential Marker of Prognosis.
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
Galectin-3 Is Associated With a Poor Prognosis in Primary Hepatocellular Carcinoma
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
LAPTM4B Allele *2 Is a Marker of Poor Prognosis Following Hepatic Tumor Resection for Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
ASPM Is a Novel Marker for Vascular Invasion, Early Recurrence, and Poor Prognosis of Hepatocellular Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Neutrophils: Driving Progression and Poor Prognosis in Hepatocellular Carcinoma?
British Journal of Cancer
Cancer Research
Oncology
Serum Anti-Eif3a Autoantibody as a Potential Diagnostic Marker for Hepatocellular Carcinoma
Scientific Reports
Multidisciplinary
Diagnostic Value of Riz1 Gene Expression as a Potential Marker for Patients With Hepatocellular Carcinoma.
International Journal of Advanced Research
Senescence Marker Protein 30 (SMP30) Serves as a Potential Prognostic Indicator in Hepatocellular Carcinoma
Scientific Reports
Multidisciplinary
Overexpression of RHEB Is Associated With Metastasis and Poor Prognosis in Hepatocellular Carcinoma
Oncology Letters
Cancer Research
Oncology
